Covered recipient · General Payments record
PATRICIA NICOLE STILLWELL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$1,014.58
- Reported across 56 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $554.25 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $156.75 | 16 |
| Gilead Sciences, Inc. | $130.98 | 5 |
| Indivior Inc. | $96.88 | 4 |
| Braeburn Inc. | $60.72 | 4 |
| Otsuka America Pharmaceutical, Inc. | $50.42 | 3 |
| Alkermes, Inc. | $45.30 | 2 |
| Vanda Pharmaceuticals Inc. | $13.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.10 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108256881 | CMS |
| ABBVIE INC. | $3.53 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108256883 | CMS |
| ABBVIE INC. | $11.07 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108256885 | CMS |
| ABBVIE INC. | $20.06 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108256887 | CMS |
| ABBVIE INC. | $10.49 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108256889 | CMS |
| ABBVIE INC. | $5.85 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108256891 | CMS |
| ABBVIE INC. | $11.65 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108256893 | CMS |
| ABBVIE INC. | $12.39 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108256895 | CMS |
| ABBVIE INC. | $14.38 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108256897 | CMS |
| ABBVIE INC. | $4.60 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108256899 | CMS |
| ABBVIE INC. | $15.08 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108256901 | CMS |
| ABBVIE INC. | $3.99 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108256903 | CMS |
| ABBVIE INC. | $5.48 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108256905 | CMS |
| ABBVIE INC. | $12.75 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108256907 | CMS |
| ABBVIE INC. | $6.88 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108256909 | CMS |
| ABBVIE INC. | $3.45 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108256911 | CMS |
| Alkermes, Inc. | $28.07 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120603443 | CMS |
| Alkermes, Inc. | $17.23 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120603445 | CMS |
| Braeburn Inc. | $15.36 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125620411 | CMS |
| Braeburn Inc. | $17.42 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125620418 | CMS |
| Braeburn Inc. | $13.26 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125620415 | CMS |
| Braeburn Inc. | $14.68 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125620422 | CMS |
| Gilead Sciences, Inc. | $77.16 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133672586 | CMS |
| Gilead Sciences, Inc. | $3.69 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133672588 | CMS |
| Gilead Sciences, Inc. | $4.14 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133672590 | CMS |
| Gilead Sciences, Inc. | $21.13 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133672592 | CMS |
| Gilead Sciences, Inc. | $24.86 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133672594 | CMS |
| Indivior Inc. | $29.33 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144572325 | CMS |
| Indivior Inc. | $20.92 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144572327 | CMS |
| Indivior Inc. | $21.44 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144572329 | CMS |
| Indivior Inc. | $25.19 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144572331 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.76 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119193500 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.66 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119193502 | CMS |
| Otsuka America Pharmaceutical, Inc. | $18.00 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119193504 | CMS |
| Vanda Pharmaceuticals Inc. | $13.20 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133971596 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.